Source:http://linkedlifedata.com/resource/pubmed/id/17910781
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
11
|
pubmed:dateCreated |
2007-11-2
|
pubmed:abstractText |
Intravenous thrombolysis with fibrinolytic drugs such as alteplase is not implemented widely in any country although the treatment is both effective and cost-effective in selected patients within a 3-h window after acute ischaemic stroke. The purpose of the present study was to describe the organisational barriers to delivery of thrombolysis for acute ischaemic stroke with special regard to the Danish healthcare system.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
1473-4877
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
23
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2833-9
|
pubmed:meshHeading | |
pubmed:year |
2007
|
pubmed:articleTitle |
Organisational barriers to thrombolysis treatment of acute ischaemic stroke.
|
pubmed:affiliation |
HTA Unit, Aarhus University Hospital, Denmark. lars.ehlers@stab.rm.dk
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|